The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
Teva Branded Pharmaceutical Products R&D, Inc., Norton (Waterford) Ltd., Teva Pharmaceuticals USA, Inc. v. FTC, et al.
2409001 Informal Interpretation
Natalia Lynch, In the Matter of
20241895: Lifespan Corporation; Medical Properties Trust, Inc.
20241895: Lifespan Corporation; MIP V Hopkins RH, L.P.
20241923: BMC Health System, Inc.; Medical Properties Trust, Inc.
20241924: BMC Health System, Inc.; MIP V Hopkins RH, L.P.
Chris Allen Hartman, In the Matter of
W. Bret Calhoun, In the Matter of
2409009 Informal Interpretation
Weblio
At the FTC’s request, a federal court has temporarily halted the operation of a sprawling business opportunity scheme that has taken in millions of dollars from consumers with bogus promises of huge returns. The scheme has operated since at least 2018 under a number of names, including “Blueprint to Wealth,” according to the FTC’s complaint. Three individuals -- Samuel James Smith, Robert William Shafer and Charles Joseph Garis, Jr. -- and a company owned by one of them -- Business Revolution Group -- are charged in the complaint with operating the scheme.
The defendants in the case agreed to settlements with the FTC that include monetary judgements, industry bans, and prohibitions on certain conduct.
2409007 Informal Interpretation
2409008 Informal Interpretation
2409003 Informal Interpretation
1Health.io/Vitagene, In the Matter of
The FTC reached a settlement with 1Health.io over allegations that it left sensitive genetic and health data unsecured, deceived consumers about their ability to get their data deleted and changed its privacy policy retroactively without adequately notifying and obtaining consent from consumers whose data the company had already collected.